DEHKORDI AH, SOLATI K, 2017- The effects of cognitive behavioral therapy and drug therapy on quality of life and symptoms of patients with irritable bowel syndrome. J Adv Pharm Technol Res, 8(2):67-72
KEATING GM, 2017- Eluxadoline: A Review in Diarrhoea- Predominant Irritable Bowel Syndrome. Drugs, 77(9):1009-1016